- Home
- FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o L-Glutamine, Phenol Red: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o L-Glutamine, Phenol Red: 1X Liquid
FluxMPS™ DCP-MEM-QR1X is a Microfluidics Suitable, ultra-filtered Minimum Essential Medium (MEM) with Earle’s Salts and Non-Essential Amino Acids (NEAA) formulation engineered for primary cell culture on organ-on-a-chip (OoC), neuronal chip, and microphysiological system (MPS) platforms. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. Formulated with Earle’s Salts, NEAA, Low Glucose (1000 mg/L), Sodium Pyruvate, and Sodium Bicarbonate; supplied without L-Glutamine and without Phenol Red for fresh nitrogen control and an imaging-clean optical baseline.
- MEM with Earle’s Salts — physiological ionic balance optimized for primary fibroblasts, neurons, epithelial, and vascular cells
- NEAA pre-loaded (Ala, Asn, Asp, Glu, Pro) — reduces de novo synthesis burden and ammonia accumulation in primary cells
- Low Glucose (1.0 g/L) — physiological carbon source for primary cell types sensitive to high glucose-induced ROS and glycation
- Quadruple-stage filtration (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final polish for sub-mycoplasma-range purity
- Endotoxin release specification < 0.05 EU/mL (LAL assay, USP <85>), controlled per manufacturing batch
- Supplied without L-Glutamine (add fresh at 2 mM at use) and without Phenol Red for an imaging-clean optical baseline
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
- Custom formulation modifications (pH, glucose, NEAA, HEPES) available on request
- Glucose1000 mg/L (1.0 g/L, Low Glucose)
- L-GlutamineNot added (add fresh, 2 mM at use)
- Sodium Pyruvate110 mg/L
- pH (USP <791>)7.4
- Osmolality (USP <785>)290–330 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack (gel ice packs, insulated packaging)
Engineered for primary cell culture where standard media fails
MEM with Earle’s Salts is the primary cell biologist’s medium — but conventional 0.22 µm–filtered MEM passes mycoplasma-range particles, subvisible particulates, and endotoxin fragments that cause subtle but significant alterations to primary cell gene expression, activation state, and morphology. FluxMPS™ is built to a finer 0.04 µm final cut-off while preserving the full MEM + NEAA nutritional profile that primary cells depend on.
Microchannel-safe purity
0.04 µm final filtration; USP <788> Method 1 (light obscuration) particulate compliance supports safe perfusion in neuronal, epithelial, and fibroblast chip architectures.
Primary cell-optimized formulation
MEM + Earle’s Salts + NEAA: the established standard for primary fibroblasts, neurons, epithelial cells, and vascular smooth muscle cells in low-serum or serum-free conditions.
Ultrapure-grade water
Ultrapure Type 1 water (18.2 MΩ·cm) processed for low trace-metal and organic carbon (TOC) content, supporting consistent primary cell culture performance lot to lot.
Below TLR4 endotoxin threshold
< 0.05 EU/mL release specification (LAL assay, USP <85>) — minimizes the risk of LPS-driven inflammatory activation that can confound primary cell phenotype, fibroblast-to-myofibroblast transition, and neuronal inflammatory responses.
NEAA reduces metabolic burden
Pre-loaded NEAA reduces the de novo synthesis burden on primary cells, improving viability in low-serum conditions and reducing ammonia accumulation from NEAA synthesis pathways.
Customization on demand
pH, glucose, NEAA concentrations, HEPES, and nutrient modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages, run as two dedicated prefilter + final-filter pairs, reaching a final 0.04 µm polish. For primary cell culture, sub-mycoplasma-range filtration is especially important — mycoplasma contamination in MEM causes altered cytokine profiles, metabolic shifts, and gene expression changes that can persist undetected for months.
-
1
0.1 µm Prefiltration I
Removes large particulates, cell debris, and protein aggregates; protects the first 0.04 µm cartridge. 0.1 µm is also the validated mycoplasma-retentive grade (A. laidlawii challenge).
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and mycoplasma-range material (0.2–0.3 µm) that would pass a standard 0.22 µm filter.
-
3
0.1 µm Prefiltration II
A second, dedicated 0.1 µm prefilter protects the second 0.04 µm cartridge, providing full redundancy for the mycoplasma-retentive barrier.
-
4
0.04 µm Final filtration II — Polish
Ultimate 0.04 µm polishing filter; aseptic fill & finish under validated ISO Class 5 (Class 100) conditions.
Performance vs. conventional MEM
© Diagnocine® — DCP-MEM-QR1X
Primary cell models & OoC applications
FluxMPS™ DCP-MEM-QR1X is purpose-built for primary cell OoC platforms where low-glucose, NEAA-supplemented, Earle’s salt–balanced conditions better mimic the physiological microenvironment than DMEM — combined with 0.04 µm filtration for particle-free chip perfusion.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant is available for automated bioreactor perfusion of primary cell cultures where trace particulates cause accelerated chip fouling.
- Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates from primary cell perfusion circuits
- Valve & Sensor Protection: Reduces micro-fouling risk in delicate neuronal and epithelial chip geometries
- Extended Perfusion Stability: Consistent NEAA and nutrient delivery over multi-week primary cell culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Neuronal Chips & Brain-on-Chip
MEM + Earle’s Salts + NEAA + low glucose is a physiologically close base for primary cortical neurons, DRG neurons, and iPSC-derived neuronal networks in microfluidic compartmentalized chips.
Epithelium-on-Chip
Low-glucose MEM with NEAA supports primary epithelial cells (intestinal, pulmonary, renal) and their barrier integrity in transwell and microfluidic TEER-monitored platforms.
Primary Fibroblast & Stromal Models
MEM with NEAA is a classical culture base for primary dermal, lung, and cardiac fibroblasts — NEAA reduces glutamine-driven ammonia accumulation that can promote myofibroblast differentiation artefacts.
Vascular Cell Culture
Earle’s salt ionic balance and low glucose support vascular smooth muscle cells (VSMCs) and primary endothelial co-culture models on vascular-on-chip platforms.
Organ-on-a-Chip & MPS
0.04 µm filtered MEM reduces particulate clogging risk in sub-100 µm neuronal and epithelial chip microchannels compared with standard 0.22 µm filtered MEM.
Microscopy & Optical Sensing
Ultra-low particulate MEM; the phenol red-free formulation reduces spectral interference, and 0.04 µm filtration minimizes background particulate scatter for confocal, TEER sensor, and biosensor applications on primary cell chips.
Analytical release specifications
Every batch released against the full specification matrix. CoA: support@diagnocine.com.
Available pack sizes: 500 mL, 1000 mL.
| Parameter | Specification |
|---|---|
| Base | MEM + Earle’s Salts + NEAA |
| Formulation | [+] Sodium Bicarbonate, [+] Calcium, [+] Magnesium, [+] Glucose, [+] Sodium Pyruvate | [-] L-Glutamine, [-] Phenol Red |
| Appearance | Pale yellow-colored, clear solution |
| Glucose | 1000 mg/L (1.0 g/L, Low Glucose) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 290–330 mOsm/kg H2O |
| Total ingredients | 35 across 3 composition groups (Inorganic Salts; Amino Acids; Vitamins & Others) |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification — see § Manufacturing & Compliance) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm / 0.04 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack (gel ice packs, insulated packaging) |
| CO2 requirement | Approximately 6% CO2 (derived from 2200 mg/L NaHCO3 at pH 7.4; validate for your application) |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
MEM with Earle’s Salts and NEAA: 35 ingredients verified per batch with CAS numbers.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 2200.000 |
| Sodium chloride | 7647-14-5 | 6800.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.500 |
| L-Alanine | 56-41-7 | 8.900 |
| L-Arginine hydrochloride | 1119-34-2 | 126.000 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 13.300 |
| L-Cystine dihydrochloride | 30925-07-6 | 31.300 |
| L-Glutamic acid | 56-86-0 | 14.700 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 52.000 |
| L-Leucine | 61-90-5 | 52.000 |
| L-Lysine hydrochloride | 657-27-2 | 72.500 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 32.000 |
| L-Proline | 147-85-3 | 11.500 |
| L-Serine | 56-45-1 | 10.500 |
| L-Threonine | 72-19-5 | 48.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 51.900 |
| L-Valine | 72-18-4 | 46.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Nicotinamide | 98-92-0 | 1.000 |
| Pyridoxal hydrochloride | 65-22-5 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 2.000 |
| D-Glucose | 50-99-7 | 1000.000 |
| Sodium pyruvate | 113-24-6 | 110.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system, with particular care for primary cell-grade purity standards.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016-certified quality management system. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm, low trace-metal and organic carbon (TOC) content for consistent primary cell culture performance.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending; Certificate of Analysis available for every batch.
Endotoxin — USP <85> BET
Release specification < 0.05 EU/mL, controlled per manufacturing batch. See the batch-level quality control note below.
Particulate — USP <788> Method 1
Light obscuration: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 290–330 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every batch on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-MEM-QR1X compares
FluxMPS™ DCP-MEM-QR1X vs. conventional 0.22 µm–filtered MEM and standard high-glucose DMEM for primary cell OoC applications.
| Parameter | DCP-MEM-QR1X (FluxMPS™) | Conventional MEM (0.22 µm filtered) |
Standard DMEM HG (0.22 µm filtered) |
|---|---|---|---|
| MEM with Earle’s Salts, NEAA, and Sodium Pyruvate without L-Glutamine and Phenol Red — imaging-clean primary cell base with fresh nitrogen control | check_circle Yes | cancel No | cancel No |
| Grade | Microfluidics Suitable (0.04 µm final cut-off) | Standard grade (0.22 µm) | Standard grade (0.22 µm) |
| Salt formulation | Earle’s Salts (bicarbonate-buffered) | Earle’s Salts | Modified Earle’s |
| NEAA included | check_circle Yes (Ala, Asn, Asp, Glu, Pro) | Optional add-on | cancel Not included |
| Glucose | 1.0 g/L (Low — physiological) | 1.0 g/L | 4.5 g/L (High) |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1 / 0.04 µm) | cancel No | cancel No |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested (Method 1) | check_circle Yes | cancel No | cancel No |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatible | check_circle Yes — Microfluidics Suitable | cancel Risk of clogging | cancel Risk of clogging |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-MEM-QR1X — MEM with Earle’s Salts and NEAA.
Supporting literature
Key publications supporting MEM with Earle’s Salts and NEAA for primary cell culture and organ-on-a-chip applications.
- Eagle H. Amino acid metabolism in mammalian cell cultures. Science. 1959;130:432–437. doi:10.1126/science.130.3373.432
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117–129. doi:10.1016/j.biomaterials.2018.07.014
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j
